The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.17
Ask: 0.21
Change: 0.01 (5.56%)
Spread: 0.04 (23.529%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.18
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Round Hill Music buys Alice In Chains catalogue

Tue, 08th Feb 2022 13:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Tuesday and not separately reported by Alliance News:

----------

Round Hill Music Royalty Fund Ltd - New York-based music copyright investment company - Acquires significant majority of the music rights for American rock band Alice In Chains. Does not disclose financial details for deal. The acquisition covers the publishing, masters and neighbouring rights of the band, including a catalogue comprising 94 compositions and 159 recordings. "Revenue from the catalogue is attributable to a diverse group of sources...In terms of geographical exposure, 75% of the revenue is from the US, while the remaining balance is from other countries," Round Hill says.

----------

Aquis Exchange PLC - London-based stock exchange operator and software developer - Partners with Investre, which is building an exchange for retail customers to buy and sell "values-driven" investment funds - either direct from the asset manager on the primary market, or by trading with other users through an auction process on the secondary market. "Aquis is providing the technology to power the secondary market, by supplying a fully outsourced technology model to Investre consisting of its award-winning Aquis Matching Engine, its Aquis Market Surveillance product, as well as ongoing operational support to the business. The duration of the contract will be three years, and the value of the contact will not be disclosed," company says.

----------

Beeks Financial Cloud Group PLC - Glasgow-based provider of connectivity for financial markets - Signs GBP2.5 million contract extension over three years with an existing unnamed tier 1 customer. The contract is for the provision of private cloud services into an additional geography, Beeks notes. Chief Executive Gordon McArthur says: "We continue to secure notable contracts with some of the world's largest players in the financial services industry, demonstrating our growing reputation and the quality of our offerings. This latest contract contributes towards underpinning our financial 2023 expectations. With growing levels of committed future revenues and a record pipeline, we are confident in continued growth."

----------

Cap-XX Ltd - New South Wales, Australia-headquartered manufacturer of ultra-thin prismatic and cylindrical supercapacitors - Wins contract from MCCI Corp, an open-source developer for LoRaWAN long-range wireless IoT networks. MCCI selects ultra-thin CAP-XX HW103 1Farad 2.75V supercap for its Model 4906 Supercap FeatherWing LoRa Module. "MCCI chose the CAP-XX supercapacitor for its thin form factor that fits easily in the Adafruit-Feather-compatible footprint, and for its low Equivalent Series Resistance which enables the high bursts of power needed for LoRa wireless data transmissions in both consumer Internet of Things and industrial IoT devices such as remote monitoring sensors," company says. Chief Executive Anthony Kongats says the deal proves how company's prismatic supercapacitors can be "excellent supporting actors" for power management in space-constrained IoT devices.

----------

LBG Media PLC - Manchester-based digital media and youth content publisher, also known as LADbible - Expects 2021 revenue to be at least GBP54 million, slightly ahead of expectations and increasing by 80% from GBP30.2 million in 2020. Adjusted earnings before interest, tax, depreciation, and amortization will be slightly ahead of market consensus of GBP16.2 million. Says direct revenue growth was driven by a significant increase in content marketing and direct display sales in the UK, Australia and Ireland. Notes indirect revenue increased significantly, primarily due to a 97% increase in views of group-generated content. Chief Executive Solly Solomou says 2021 performance "outstanding, both financially and operationally".

----------

Nuformix PLC - London-based pharmaceutical development firm focused on fibrosis and oncology via drug repurposing - After signing exclusive global licensing agreement with Oxilio Ltd for NXP001 in September, Oxilio progresses product and signs "significant" service contract with Quotient Sciences Ltd to support the formulation development of NXP001. This is a proprietary new form of aprepitant which is currently marketed for cancer chemotherapy induced nausea and vomiting. "Under the contract Oxilio will work with Quotient Sciences, a drug development and manufacturing accelerator, to identify and evaluate the cocrystal formulation of aprepitant to deliver optimal bioavailability for the treatment of CINV," Nuformix explains.

----------

Armadale Capital PLC - investment company focussed on mining projects in Africa - Makes further progress developing the mining lease at the Mahenge Liandu project in Tanzania, as part of its plans to commission commercial operations. Applies for three incremental exploration licences, which it hopes will "materially enhance" the Mahenge Liandu project's exploration potential.

----------

Riverstone Energy Ltd - Guernsey-based investor in energy companies and assets - Will sell its entire stake in Pipestone Energy Corp for CAD53.0 million, about GBP30.8 million. Riverstone says it will use the proceeds as part of its plan to recommence its share buyback programme. Riverstone said it decided to allocate an additional GBP46 million to the GBP40 million programme launched last May. It already has repurchased 7.7 million shares at a total cost of GBP36 million.

----------

Eco Atlantic Oil & Gas Ltd - oil and gas exploration company focused on Guyana and Namibia - Signs definitive share purchase agreement to buy 100% of Azinam Group Ltd in return for a 16.5% equity stake in the company. Co-Founder & Chief Executive Gil Holzman says: "This now puts the company a step further towards joining all of Azinam's offshore exploration acreage into our broader portfolio. We are working towards drilling a well on Block 2B, a highly prospective play in the Orange Basin, offshore South Africa, close to the recent discovery by Shell PLC and Qatar Energy in the Orange Basin in Namibia. The well is planned for the second half of this year." Azinam owns a portfolio of offshore petroleum assets in Namibia and South Africa.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
28 Jul 2022 16:14

EXECUTIVE CHANGES: Cohort co-founder out; Nuformix co-founder back

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

Read more
28 Jul 2022 15:01

EARNINGS UPDATES: Alliance Trust beats benchmark and ups dividend

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Jun 2022 12:25

IN BRIEF: Nuformix shares rise as progresses with cancer programme

Nuformix PLC - London-based pharmaceutical development firm focused on fibrosis and oncology via drug repurposing - Starts to scale-up the production processes of lead cocrystals for its cancer programme NXP004, focused on the treatment for advanced ovarian cancer. Firm aims to develop new forms of Olaparib, "currently marketed by AstraZeneca PLC, under the Lynparza brand name," Nuformix explains. First approved in 2014 for advanced ovarian cancer, it has since received "similar approvals in breast, pancreatic and prostate cancers with further trials on-going."

Read more
27 Jun 2022 21:51

TRADING UPDATES: Anglo-Eastern Plantations sees palm oil prices rise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
31 May 2022 12:41

Nuformix Executive Chair Alastair Riddell resigns after one year

(Alliance News) - Nuformix PLC on Tuesday said Executive Chair Alastair Riddell has resigned with immediate effect.

Read more
30 May 2022 11:54

IN BRIEF: Nuformix shares plunge on inconsistent repeat study results

Nuformix PLC - London-based pharmaceutical development firm focused on fibrosis and oncology via drug repurposing - Says the contract research organisation undertaking the final planned pre-clinical study for its NXP002 treatment had a protocol failure, which has voided the study. Says the organisation repeated the study and recorded results that were inconsistent with the first in vivo study at all time points and also with the oral control. Notes that no positive or negative conclusions could be drawn from this study.

Read more
30 May 2022 11:13

SMALL-CAP WINNERS & LOSERS: Foxtons finds new CEO; S4 revenue surges

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
28 Mar 2022 19:18

IN BRIEF: Nuformix NXP004 patent application reaches publication phase

Nuformix PLC - London-based pharmaceutical development firm focused on fibrosis and oncology via drug repurposing - Says patent application for key asset NXP004 had progressed to the publication phase. NXP004 is a new formulation of Olaparib, which is used to treat ovarian, breast and pancreatic cancers currently marketed by FTSE 100-listed AstraZeneca PLC, under the name Lynparza. The patent application, which was made in September 2020, covers new olaparib oxalic acid cocrystals, their therapeutic uses and pharmaceutical compositions containing them. A second patent application was filed last November which remains pending.

Read more
8 Feb 2022 10:52

SMALL-CAP WINNERS & LOSERS: Nuformix jumps as partner inks contract

SMALL-CAP WINNERS & LOSERS: Nuformix jumps as partner inks contract

Read more
14 Dec 2021 18:01

TRADING UPDATES: Cohort interim loss widens, Yourgene loss narrows

TRADING UPDATES: Cohort interim loss widens, Yourgene loss narrows

Read more
25 Nov 2021 16:23

IN BRIEF: Nuformix notes positive results for inhaled NXP002 dose

IN BRIEF: Nuformix notes positive results for inhaled NXP002 dose

Read more
12 Nov 2021 12:11

TRADING UPDATES: Princess exits Taco Bell; Nuformix files patent

TRADING UPDATES: Princess exits Taco Bell; Nuformix files patent

Read more
12 Nov 2021 10:54

SMALL-CAP WINNERS & LOSERS: Avon Protection plates face approval delay

SMALL-CAP WINNERS & LOSERS: Avon Protection plates face approval delay

Read more
9 Nov 2021 15:30

CORRECT: Nuformix Chair Alastair Riddell to move to executive chair

CORRECT: Nuformix Chair Alastair Riddell to move to executive chair

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.